[Efficacy of betaserk in experimental motor disease].
Mantsev
E I
EI
Sigaleva
E E
EE
D000293:Adolescent; D000328:Adult; D001621:Betahistine / Q000627:therapeutic use*; D017442:Histamine Agonists / Q000627:therapeutic use*; D006801:Humans; D009041:Motion Sickness / Q000188:drug therapy* / Q000503:physiopathology; D012016:Reference Values; D016896:Treatment Outcome; D014722:Vestibule, Labyrinth / Q000187:drug effects / Q000503:physiopathology
D017442:Histamine Agonists; D001621:Betahistine